Home > Healthcare > Pharmaceuticals > Disease Specific Drugs > Periodontal Therapeutics Market

Periodontal Therapeutics Market Share

Report ID: GMI9920
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

Periodontal Therapeutics Market Share

The periodontal therapeutics sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovations such as the application of regenerative medicine, including the use of growth factors and stem cell therapy.

Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Periodontal Therapeutics Market Companies

Some of the eminent market participants operating in the periodontal therapeutics industry include:

Align Technology, Inc.
Bausch Health Companies Inc.
Cadila Healthcare Ltd.
Colgate-Palmolive Company
Danaher Corporation
Den-Mat Holdings LLC
Dentsply Sirona
Dexcel Pharma Technologies Ltd.
GlaxoSmithKline plc
Henry Schein, Inc.
Hoffmann-La Roche Ltd.
Johnson & Johnson Services, Inc.
Kaken Pharmaceutical Co., Ltd.
Pfizer Inc.
Procter & Gamble Co.
Straumann Holding AG
Sunstar Suisse SA
Teva Pharmaceutical Industries Ltd.
Zimmer Biomet Holdings, Inc.
3M Company

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

Global periodontal therapeutics industry was valued at USD 849.2 billion in 2023 and is anticipated to register 7.7% CAGR between 2024 and 2032, driven by growing prevalence of periodontal diseases and increasing awareness about oral health.

The retail pharmacies segment in the market recorded USD 351.1 million in 2023 owing to the increasing prevalence of periodontal diseases, such as gingivitis and periodontitis, driven by aging populations, poor oral hygiene, and lifestyle factors.

North America periodontal therapeutics market is forecasted to reach USD 756.7 million by 2032, propelled by rapidly aging population, technological advancements, heightened public awareness, and the rising prevalence of chronic diseases.

Align Technology, Inc., Bausch Health Companies Inc., Cadila Healthcare Ltd., Colgate-Palmolive Company, Danaher Corporation, Den-Mat Holdings LLC, Dentsply Sirona, Dexcel Pharma Technologies Ltd., and GlaxoSmithKline plc, among others.